A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL

NCT05885386 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pheochromocytoma
Paraganglioma

Interventions

DRUG: Temozolomide

Sponsor

Peking Union Medical College Hospital